N-[(25Z)-14-[(9Z)-9-Octadecen-1-yloxy]-3,6,9,12,16-pentaoxatetratriacont-25-en-1-yl]-1H-imidazole-5-carboxamide

Request For Quotation
N-[(25Z)-14-[(9Z)-9-Octadecen-1-yloxy]-3,6,9,12,16-pentaoxatetratriacont-25-en-1-yl]-1H-imidazole-5-carboxamide Suppliers list
Company Name: Shanghai Yifei Biotechnology Co. , Ltd.  
Tel: 021-65675885 18964387627
Email: customer_service@efebio.com
Company Name: Jilin Chinese Academy of Sciences-yanshen Technology  
Tel: 18143011203
Email: ET-market@chemextension.com
Company Name: Shandong Dayou Pharmaceutical Research and Development Co., Ltd.  
Tel: hanfangpharma@126.com 15165037910
Email: hanfangpharma@126.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
N-[(25Z)-14-[(9Z)-9-Octadecen-1-yloxy]-3,6,9,12,16-pentaoxatetratriacont-25-en-1-yl]-1H-imidazole-5-carboxamide Basic information
Product Name:N-[(25Z)-14-[(9Z)-9-Octadecen-1-yloxy]-3,6,9,12,16-pentaoxatetratriacont-25-en-1-yl]-1H-imidazole-5-carboxamide
Synonyms:N-[(25Z)-14-[(9Z)-9-Octadecen-1-yloxy]-3,6,9,12,16-pentaoxatetratriacont-25-en-1-yl]-1H-imidazole-5-carboxamide;DOG-IM4
CAS:2758097-38-8
MF:C51H95N3O7
MW:862.32
EINECS:
Product Categories:
Mol File:2758097-38-8.mol
N-[(25Z)-14-[(9Z)-9-Octadecen-1-yloxy]-3,6,9,12,16-pentaoxatetratriacont-25-en-1-yl]-1H-imidazole-5-carboxamide Structure
N-[(25Z)-14-[(9Z)-9-Octadecen-1-yloxy]-3,6,9,12,16-pentaoxatetratriacont-25-en-1-yl]-1H-imidazole-5-carboxamide Chemical Properties
Boiling point 882.3±65.0 °C(Predicted)
density 0.972±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)
solubility Ethanol: 10 mg/ml
pka11.73±0.10(Predicted)
Safety Information
MSDS Information
N-[(25Z)-14-[(9Z)-9-Octadecen-1-yloxy]-3,6,9,12,16-pentaoxatetratriacont-25-en-1-yl]-1H-imidazole-5-carboxamide Usage And Synthesis
UsesDOG-IM4 can be used to synthesize nanoparticles to deliver antigen-encoding nucleic acids. It could be used to try to target autoimmune diseases, rare blood or metabolic diseases, allergies, cancer or infectious diseases[1].
References[1] Synthesis of lipids for nanoparticle delivery of therapeutic agents. World Intellectual Property Organization, WO2022013443 A1 2022-01-20.
[2] MANON RIPOLL . An imidazole modified lipid confers enhanced mRNA-LNP stability and strong immunization properties in mice and non-human primates[J]. Biomaterials, 2022, 286: Article 121570. DOI: 10.1016/j.biomaterials.2022.121570
N-[(25Z)-14-[(9Z)-9-Octadecen-1-yloxy]-3,6,9,12,16-pentaoxatetratriacont-25-en-1-yl]-1H-imidazole-5-carboxamide Preparation Products And Raw materials
Tag:N-[(25Z)-14-[(9Z)-9-Octadecen-1-yloxy]-3,6,9,12,16-pentaoxatetratriacont-25-en-1-yl]-1H-imidazole-5-carboxamide(2758097-38-8) Related Product Information
31hP 244cis Decanoic acid, 2-octyl-, 7-[(2-hydroxyethyl)[8-(nonyloxy)-8-oxooctyl]amino]heptyl ester 4-O10b1 Propanoic acid, 3-[[4-[[2-(dimethylamino)ethyl]amino]-3-[(2-hexyl-1-oxodecyl)amino]-4-oxobutyl]thio]-, (9Z)-9-octadecen-1-yl ester DSPE-PEG-OH